We also detected plasma TGF-β levels in three groups of subjects and found that TGF-β concentration in plasma of LC patients was significantly lower than that in HC subjects and CHB patients (Supplemental Fig. 1). This evidence concerns the gene TGFB1 and laryngotracheoesophageal cleft.